Clinical trials have demonstrated the safety of transcranial magnetic stimulation in treating patients who have had an inadequate response to prior antidepressant medications. The first major clinical trial in the U.S. involved the NeurostarTMS device, our first TMS machine.
Treatment with TMS caused very few side effects and was generally well tolerated by patients. The most common side effect reported during clinical trials was scalp discomfort—generally mild to moderate and occurring less frequently after the first week of treatment.
Fewer than 5% of patients discontinued treatment with NeurostarTMS Therapy due to adverse events.
Over 10,000 active treatments were performed across all NeuroStar® clinical trials demonstrating its safety
No systemic side effects
TMS is the breakthrough technology for non-drug treatment of depression and promises to be the future of psychiatric treatment—providing hope for patients for whom medication treatment and psychotherapy have failed to achieve satisfactory results. At TMS of Knoxville, we have successfully treated many patients with treatment resistant depression
